Prehab before cancer surgery may boost recovery
NCT ID NCT07464457
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a program of targeted exercise and psychological support before cancer treatment (called prehabilitation) can help patients with solid tumors recover better physically and emotionally. Researchers will compare this program to standard care in 125 adults with breast cancer or other solid tumors. The main goal is to see if prehabilitation improves walking ability, strength, and quality of life after surgery or radiation.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- targeted exercise and psycho-oncological support program
- What this could lead to
- If it works, this could show that a pre-treatment program of exercise and counseling helps cancer patients recover faster and feel better after surgery or radiation.
- What could go wrong
- This is a small, early-stage study with only 125 participants, so results may not apply to all patients. The program requires time and effort, and some patients may not benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 125 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Mar 2026
An estimate. Start dates often move.
- Expected to finish
-
Oct 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients with solid tumors (focus on breastcancer) * Curative-intent multimodal treatment concept with local surgical or radiotherapeutic ablation * Working age and \> 18 years * ECOG 0-2 * Sufficient language skills to understand questionnaires/training instructions Exclusion Criteria: * Severe cardiac or pulmonary comorbidities that do not allow participation in the program * Medical contraindications for physical activity * Lack of patient capacity to consent * Pregnancy/breastfeeding * Acute infections/fever * Participation in another clinical intervention study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University hospital Münster
RECRUITINGMünster, North Rhine-Westphalia, 48149, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common steroid shield breast cancer patients from a dangerous drug side effect?
- Tiny magnetic seeds could guide surgeons to the right lymph node
- New PET tracer aims to light up hidden cancer targets
- Gut bacteria supplement tested against chemo hair loss
- Can a mindfulness program boost Self-Compassion in breast cancer survivors?
- First human test of BI 4060107 aims to find safe dose for Hard-to-Treat tumors